Global Human Cytomegalovirus Envelope Glycoprotein B Market Insights, Forecast to 2029

The global Human Cytomegalovirus Envelope Glycoprotein B market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Human Cytomegalovirus Envelope Glycoprotein B is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Human Cytomegalovirus Envelope Glycoprotein B is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Human Cytomegalovirus Envelope Glycoprotein B is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key manufacturers of Human Cytomegalovirus Envelope Glycoprotein B include Astellas Pharma Inc., Trellis Bioscience, Inc., Vakzine Projekt Management GmbH, VBI Vaccine Inc and Vical Incorporated, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes:

This report presents an overview of global market for Human Cytomegalovirus Envelope Glycoprotein B, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Human Cytomegalovirus Envelope Glycoprotein B, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Human Cytomegalovirus Envelope Glycoprotein B, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Cytomegalovirus Envelope Glycoprotein B sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Human Cytomegalovirus Envelope Glycoprotein B market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Human Cytomegalovirus Envelope Glycoprotein B sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Astellas Pharma Inc., Trellis Bioscience, Inc., Vakzine Projekt Management GmbH, VBI Vaccine Inc and Vical Incorporated, etc.

1.1 Human Cytomegalovirus Envelope Glycoprotein B Product Introduction

1.2 Market by Type

1.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 CSJ-148

1.2.3 CyMVectin

1.2.4 TRL-345

1.2.5 PPCM

1.2.6 Cytomegalovirus Vaccine

1.2.7 Others

1.3 Market by Application

1.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Infectious Disease

1.3.3 Oncology

1.3.4 Women's Health

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Estimates and Forecasts 2018-2029

2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region

2.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region: 2018 VS 2022 VS 2029

2.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2018-2023)

2.2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2024-2029)

2.2.4 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2018-2029)

2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Estimates and Forecasts 2018-2029

2.4 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region

2.4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region: 2018 VS 2022 VS 2029

2.4.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2018-2023)

2.4.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2024-2029)

2.4.4 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2018-2029)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Manufacturers

3.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Manufacturers (2018-2023)

3.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Manufacturers (2018-2023)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Cytomegalovirus Envelope Glycoprotein B in 2022

3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Manufacturers

3.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Manufacturers (2018-2023)

3.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Manufacturers (2018-2023)

3.2.3 Global Top 10 and Top 5 Companies by Human Cytomegalovirus Envelope Glycoprotein B Revenue in 2022

3.3 Global Key Players of Human Cytomegalovirus Envelope Glycoprotein B, Industry Ranking, 2021 VS 2022 VS 2023

3.4 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Human Cytomegalovirus Envelope Glycoprotein B, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Human Cytomegalovirus Envelope Glycoprotein B, Product Offered and Application

3.8 Global Key Manufacturers of Human Cytomegalovirus Envelope Glycoprotein B, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type

4.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Historical Sales by Type (2018-2023)

4.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Forecasted Sales by Type (2024-2029)

4.1.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2018-2029)

4.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type

4.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Historical Revenue by Type (2018-2023)

4.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Forecasted Revenue by Type (2024-2029)

4.2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2018-2029)

4.3 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Type

4.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2018-2023)

4.3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Price Forecast by Type (2024-2029)

5.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application

5.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Historical Sales by Application (2018-2023)

5.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Forecasted Sales by Application (2024-2029)

5.1.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2018-2029)

5.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application

5.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Historical Revenue by Application (2018-2023)

5.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Forecasted Revenue by Application (2024-2029)

5.2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2018-2029)

5.3 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Application

5.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Application (2018-2023)

5.3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Price Forecast by Application (2024-2029)

6.1 US & Canada Human Cytomegalovirus Envelope Glycoprotein B Market Size by Type

6.1.1 US & Canada Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2018-2029)

6.1.2 US & Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2018-2029)

6.2 US & Canada Human Cytomegalovirus Envelope Glycoprotein B Market Size by Application

6.2.1 US & Canada Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2018-2029)

6.2.2 US & Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2018-2029)

6.3 US & Canada Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country

6.3.1 US & Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country: 2018 VS 2022 VS 2029

6.3.2 US & Canada Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2018-2029)

6.3.3 US & Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2018-2029)

6.3.4 US

6.3.5 Canada

7.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size by Type

7.1.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2018-2029)

7.1.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2018-2029)

7.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size by Application

7.2.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2018-2029)

7.2.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2018-2029)

7.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country

7.3.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country: 2018 VS 2022 VS 2029

7.3.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2018-2029)

7.3.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2018-2029)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8.1 China Human Cytomegalovirus Envelope Glycoprotein B Market Size

8.1.1 China Human Cytomegalovirus Envelope Glycoprotein B Sales (2018-2029)

8.1.2 China Human Cytomegalovirus Envelope Glycoprotein B Revenue (2018-2029)

8.2 China Human Cytomegalovirus Envelope Glycoprotein B Market Size by Application

8.2.1 China Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2018-2029)

8.2.2 China Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2018-2029)

9.1 Asia Human Cytomegalovirus Envelope Glycoprotein B Market Size by Type

9.1.1 Asia Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2018-2029)

9.1.2 Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2018-2029)

9.2 Asia Human Cytomegalovirus Envelope Glycoprotein B Market Size by Application

9.2.1 Asia Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2018-2029)

9.2.2 Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2018-2029)

9.3 Asia Human Cytomegalovirus Envelope Glycoprotein B Sales by Region

9.3.1 Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region: 2018 VS 2022 VS 2029

9.3.2 Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2018-2029)

9.3.3 Asia Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2018-2029)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10.1 Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Type

10.1.1 Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2018-2029)

10.1.2 Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2018-2029)

10.2 Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Application

10.2.1 Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2018-2029)

10.2.2 Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2018-2029)

10.3 Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country

10.3.1 Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country: 2018 VS 2022 VS 2029

10.3.2 Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2018-2029)

10.3.3 Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2018-2029)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11.1 Astellas Pharma Inc.

11.1.1 Astellas Pharma Inc. Company Information

11.1.2 Astellas Pharma Inc. Overview

11.1.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Revenue and Gross Margin (2018-2023)

11.1.4 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Astellas Pharma Inc. Recent Developments

11.2 Trellis Bioscience, Inc.

11.2.1 Trellis Bioscience, Inc. Company Information

11.2.2 Trellis Bioscience, Inc. Overview

11.2.3 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Revenue and Gross Margin (2018-2023)

11.2.4 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Trellis Bioscience, Inc. Recent Developments

11.3 Vakzine Projekt Management GmbH

11.3.1 Vakzine Projekt Management GmbH Company Information

11.3.2 Vakzine Projekt Management GmbH Overview

11.3.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Revenue and Gross Margin (2018-2023)

11.3.4 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Vakzine Projekt Management GmbH Recent Developments

11.4 VBI Vaccine Inc

11.4.1 VBI Vaccine Inc Company Information

11.4.2 VBI Vaccine Inc Overview

11.4.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Revenue and Gross Margin (2018-2023)

11.4.4 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 VBI Vaccine Inc Recent Developments

11.5 Vical Incorporated

11.5.1 Vical Incorporated Company Information

11.5.2 Vical Incorporated Overview

11.5.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Revenue and Gross Margin (2018-2023)

11.5.4 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Vical Incorporated Recent Developments

12.1 Human Cytomegalovirus Envelope Glycoprotein B Industry Chain Analysis

12.2 Human Cytomegalovirus Envelope Glycoprotein B Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Human Cytomegalovirus Envelope Glycoprotein B Production Mode & Process

12.4 Human Cytomegalovirus Envelope Glycoprotein B Sales and Marketing

12.4.1 Human Cytomegalovirus Envelope Glycoprotein B Sales Channels

12.4.2 Human Cytomegalovirus Envelope Glycoprotein B Distributors

12.5 Human Cytomegalovirus Envelope Glycoprotein B Customers

13.1 Human Cytomegalovirus Envelope Glycoprotein B Industry Trends

13.2 Human Cytomegalovirus Envelope Glycoprotein B Market Drivers

13.3 Human Cytomegalovirus Envelope Glycoprotein B Market Challenges

13.4 Human Cytomegalovirus Envelope Glycoprotein B Market Restraints

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

List of Tables

    Table 1. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

    Table 2. Major Manufacturers of CSJ-148

    Table 3. Major Manufacturers of CyMVectin

    Table 4. Major Manufacturers of TRL-345

    Table 5. Major Manufacturers of PPCM

    Table 6. Major Manufacturers of Cytomegalovirus Vaccine

    Table 7. Major Manufacturers of Others

    Table 8. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

    Table 9. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 10. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2018-2023) & (US$ Million)

    Table 11. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2024-2029) & (US$ Million)

    Table 12. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2018-2023)

    Table 13. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2024-2029)

    Table 14. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 15. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2018-2023) & (K Pcs)

    Table 16. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2024-2029) & (K Pcs)

    Table 17. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2018-2023)

    Table 18. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2024-2029)

    Table 19. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Manufacturers (2018-2023) & (K Pcs)

    Table 20. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Manufacturers (2018-2023)

    Table 21. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Manufacturers (2018-2023) & (US$ Million)

    Table 22. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Manufacturers (2018-2023)

    Table 23. Global Key Players of Human Cytomegalovirus Envelope Glycoprotein B, Industry Ranking, 2021 VS 2022 VS 2023

    Table 24. Human Cytomegalovirus Envelope Glycoprotein B Price by Manufacturers 2018-2023 (USD/Pcs)

    Table 25. Global Human Cytomegalovirus Envelope Glycoprotein B Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 26. Global Human Cytomegalovirus Envelope Glycoprotein B by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Cytomegalovirus Envelope Glycoprotein B as of 2022)

    Table 27. Global Key Manufacturers of Human Cytomegalovirus Envelope Glycoprotein B, Manufacturing Base Distribution and Headquarters

    Table 28. Global Key Manufacturers of Human Cytomegalovirus Envelope Glycoprotein B, Product Offered and Application

    Table 29. Global Key Manufacturers of Human Cytomegalovirus Envelope Glycoprotein B, Date of Enter into This Industry

    Table 30. Mergers & Acquisitions, Expansion Plans

    Table 31. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2018-2023) & (K Pcs)

    Table 32. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2024-2029) & (K Pcs)

    Table 33. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Type (2018-2023)

    Table 34. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Type (2024-2029)

    Table 35. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2018-2023) & (US$ Million)

    Table 36. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2024-2029) & (US$ Million)

    Table 37. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Type (2018-2023)

    Table 38. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Type (2024-2029)

    Table 39. Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2018-2023) & (USD/Pcs)

    Table 40. Global Human Cytomegalovirus Envelope Glycoprotein B Price Forecast by Type (2024-2029) & (USD/Pcs)

    Table 41. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2018-2023) & (K Pcs)

    Table 42. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2024-2029) & (K Pcs)

    Table 43. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Application (2018-2023)

    Table 44. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Application (2024-2029)

    Table 45. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2018-2023) & (US$ Million)

    Table 46. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2024-2029) & (US$ Million)

    Table 47. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Application (2018-2023)

    Table 48. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Application (2024-2029)

    Table 49. Human Cytomegalovirus Envelope Glycoprotein B Price by Application (2018-2023) & (USD/Pcs)

    Table 50. Global Human Cytomegalovirus Envelope Glycoprotein B Price Forecast by Application (2024-2029) & (USD/Pcs)

    Table 51. US & Canada Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2018-2023) & (K Pcs)

    Table 52. US & Canada Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2024-2029) & (K Pcs)

    Table 53. US & Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2018-2023) & (US$ Million)

    Table 54. US & Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2024-2029) & (US$ Million)

    Table 55. US & Canada Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2018-2023) & (K Pcs)

    Table 56. US & Canada Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2024-2029) & (K Pcs)

    Table 57. US & Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2018-2023) & (US$ Million)

    Table 58. US & Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2024-2029) & (US$ Million)

    Table 59. US & Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 60. US & Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2018-2023) & (US$ Million)

    Table 61. US & Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2024-2029) & (US$ Million)

    Table 62. US & Canada Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2018-2023) & (K Pcs)

    Table 63. US & Canada Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2024-2029) & (K Pcs)

    Table 64. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2018-2023) & (K Pcs)

    Table 65. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2024-2029) & (K Pcs)

    Table 66. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2018-2023) & (US$ Million)

    Table 67. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2024-2029) & (US$ Million)

    Table 68. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2018-2023) & (K Pcs)

    Table 69. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2024-2029) & (K Pcs)

    Table 70. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2018-2023) & (US$ Million)

    Table 71. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2024-2029) & (US$ Million)

    Table 72. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 73. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2018-2023) & (US$ Million)

    Table 74. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2024-2029) & (US$ Million)

    Table 75. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2018-2023) & (K Pcs)

    Table 76. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2024-2029) & (K Pcs)

    Table 77. China Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2018-2023) & (K Pcs)

    Table 78. China Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2024-2029) & (K Pcs)

    Table 79. China Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2018-2023) & (US$ Million)

    Table 80. China Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2024-2029) & (US$ Million)

    Table 81. China Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2018-2023) & (K Pcs)

    Table 82. China Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2024-2029) & (K Pcs)

    Table 83. China Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2018-2023) & (US$ Million)

    Table 84. China Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2024-2029) & (US$ Million)

    Table 85. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2018-2023) & (K Pcs)

    Table 86. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2024-2029) & (K Pcs)

    Table 87. Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2018-2023) & (US$ Million)

    Table 88. Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2024-2029) & (US$ Million)

    Table 89. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2018-2023) & (K Pcs)

    Table 90. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2024-2029) & (K Pcs)

    Table 91. Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2018-2023) & (US$ Million)

    Table 92. Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2024-2029) & (US$ Million)

    Table 93. Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 94. Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2018-2023) & (US$ Million)

    Table 95. Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2024-2029) & (US$ Million)

    Table 96. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2018-2023) & (K Pcs)

    Table 97. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2024-2029) & (K Pcs)

    Table 98. Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2018-2023) & (K Pcs)

    Table 99. Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2024-2029) & (K Pcs)

    Table 100. Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2018-2023) & (US$ Million)

    Table 101. Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2024-2029) & (US$ Million)

    Table 102. Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2018-2023) & (K Pcs)

    Table 103. Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2024-2029) & (K Pcs)

    Table 104. Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2018-2023) & (US$ Million)

    Table 105. Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2024-2029) & (US$ Million)

    Table 106. Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 107. Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2018-2023) & (US$ Million)

    Table 108. Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2024-2029) & (US$ Million)

    Table 109. Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2018-2023) & (K Pcs)

    Table 110. Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2024-2029) & (K Pcs)

    Table 111. Astellas Pharma Inc. Company Information

    Table 112. Astellas Pharma Inc. Description and Major Businesses

    Table 113. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 114. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Model Numbers, Pictures, Descriptions and Specifications

    Table 115. Astellas Pharma Inc. Recent Developments

    Table 116. Trellis Bioscience, Inc. Company Information

    Table 117. Trellis Bioscience, Inc. Description and Major Businesses

    Table 118. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 119. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Model Numbers, Pictures, Descriptions and Specifications

    Table 120. Trellis Bioscience, Inc. Recent Developments

    Table 121. Vakzine Projekt Management GmbH Company Information

    Table 122. Vakzine Projekt Management GmbH Description and Major Businesses

    Table 123. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 124. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Model Numbers, Pictures, Descriptions and Specifications

    Table 125. Vakzine Projekt Management GmbH Recent Developments

    Table 126. VBI Vaccine Inc Company Information

    Table 127. VBI Vaccine Inc Description and Major Businesses

    Table 128. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 129. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Model Numbers, Pictures, Descriptions and Specifications

    Table 130. VBI Vaccine Inc Recent Developments

    Table 131. Vical Incorporated Company Information

    Table 132. Vical Incorporated Description and Major Businesses

    Table 133. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 134. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Model Numbers, Pictures, Descriptions and Specifications

    Table 135. Vical Incorporated Recent Developments

    Table 136. Key Raw Materials Lists

    Table 137. Raw Materials Key Suppliers Lists

    Table 138. Human Cytomegalovirus Envelope Glycoprotein B Distributors List

    Table 139. Human Cytomegalovirus Envelope Glycoprotein B Customers List

    Table 140. Human Cytomegalovirus Envelope Glycoprotein B Market Trends

    Table 141. Human Cytomegalovirus Envelope Glycoprotein B Market Drivers

    Table 142. Human Cytomegalovirus Envelope Glycoprotein B Market Challenges

    Table 143. Human Cytomegalovirus Envelope Glycoprotein B Market Restraints

    Table 144. Research Programs/Design for This Report

    Table 145. Key Data Information from Secondary Sources

    Table 146. Key Data Information from Primary Sources

List of Figures

    Figure 1. Human Cytomegalovirus Envelope Glycoprotein B Product Picture

    Figure 2. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

    Figure 3. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Type in 2022 & 2029

    Figure 4. CSJ-148 Product Picture

    Figure 5. CyMVectin Product Picture

    Figure 6. TRL-345 Product Picture

    Figure 7. PPCM Product Picture

    Figure 8. Cytomegalovirus Vaccine Product Picture

    Figure 9. Others Product Picture

    Figure 10. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

    Figure 11. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Application in 2022 & 2029

    Figure 12. Infectious Disease

    Figure 13. Oncology

    Figure 14. Women's Health

    Figure 15. Others

    Figure 16. Human Cytomegalovirus Envelope Glycoprotein B Report Years Considered

    Figure 17. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 18. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue 2018-2029 (US$ Million)

    Figure 19. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region in Percentage: 2022 Versus 2029

    Figure 20. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2018-2029)

    Figure 21. Global Human Cytomegalovirus Envelope Glycoprotein B Sales 2018-2029 ((K Pcs)

    Figure 22. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2018-2029)

    Figure 23. US & Canada Human Cytomegalovirus Envelope Glycoprotein B Sales YoY (2018-2029) & (K Pcs)

    Figure 24. US & Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue YoY (2018-2029) & (US$ Million)

    Figure 25. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales YoY (2018-2029) & (K Pcs)

    Figure 26. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue YoY (2018-2029) & (US$ Million)

    Figure 27. China Human Cytomegalovirus Envelope Glycoprotein B Sales YoY (2018-2029) & (K Pcs)

    Figure 28. China Human Cytomegalovirus Envelope Glycoprotein B Revenue YoY (2018-2029) & (US$ Million)

    Figure 29. Asia (excluding China) Human Cytomegalovirus Envelope Glycoprotein B Sales YoY (2018-2029) & (K Pcs)

    Figure 30. Asia (excluding China) Human Cytomegalovirus Envelope Glycoprotein B Revenue YoY (2018-2029) & (US$ Million)

    Figure 31. Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales YoY (2018-2029) & (K Pcs)

    Figure 32. Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue YoY (2018-2029) & (US$ Million)

    Figure 33. The Human Cytomegalovirus Envelope Glycoprotein B Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022

    Figure 34. The Top 5 and 10 Largest Manufacturers of Human Cytomegalovirus Envelope Glycoprotein B in the World: Market Share by Human Cytomegalovirus Envelope Glycoprotein B Revenue in 2022

    Figure 35. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

    Figure 36. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2018-2029)

    Figure 37. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2018-2029)

    Figure 38. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2018-2029)

    Figure 39. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2018-2029)

    Figure 40. US & Canada Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2018-2029)

    Figure 41. US & Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2018-2029)

    Figure 42. US & Canada Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2018-2029)

    Figure 43. US & Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2018-2029)

    Figure 44. US & Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Country (2018-2029)

    Figure 45. US & Canada Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Country (2018-2029)

    Figure 46. U.S. Human Cytomegalovirus Envelope Glycoprotein B Revenue (2018-2029) & (US$ Million)

    Figure 47. Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue (2018-2029) & (US$ Million)

    Figure 48. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2018-2029)

    Figure 49. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2018-2029)

    Figure 50. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2018-2029)

    Figure 51. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2018-2029)

    Figure 52. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Country (2018-2029)

    Figure 53. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Country (2018-2029)

    Figure 54. Germany Human Cytomegalovirus Envelope Glycoprotein B Revenue (2018-2029) & (US$ Million)

    Figure 55. France Human Cytomegalovirus Envelope Glycoprotein B Revenue (2018-2029) & (US$ Million)

    Figure 56. U.K. Human Cytomegalovirus Envelope Glycoprotein B Revenue (2018-2029) & (US$ Million)

    Figure 57. Italy Human Cytomegalovirus Envelope Glycoprotein B Revenue (2018-2029) & (US$ Million)

    Figure 58. Russia Human Cytomegalovirus Envelope Glycoprotein B Revenue (2018-2029) & (US$ Million)

    Figure 59. China Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2018-2029)

    Figure 60. China Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2018-2029)

    Figure 61. China Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2018-2029)

    Figure 62. China Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2018-2029)

    Figure 63. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2018-2029)

    Figure 64. Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2018-2029)

    Figure 65. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2018-2029)

    Figure 66. Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2018-2029)

    Figure 67. Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Region (2018-2029)

    Figure 68. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Region (2018-2029)

    Figure 69. Japan Human Cytomegalovirus Envelope Glycoprotein B Revenue (2018-2029) & (US$ Million)

    Figure 70. South Korea Human Cytomegalovirus Envelope Glycoprotein B Revenue (2018-2029) & (US$ Million)

    Figure 71. China Taiwan Human Cytomegalovirus Envelope Glycoprotein B Revenue (2018-2029) & (US$ Million)

    Figure 72. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue (2018-2029) & (US$ Million)

    Figure 73. India Human Cytomegalovirus Envelope Glycoprotein B Revenue (2018-2029) & (US$ Million)

    Figure 74. Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2018-2029)

    Figure 75. Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2018-2029)

    Figure 76. Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2018-2029)

    Figure 77. Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2018-2029)

    Figure 78. Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Country (2018-2029)

    Figure 79. Middle East, Africa and Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Country (2018-2029)

    Figure 80. Brazil Human Cytomegalovirus Envelope Glycoprotein B Revenue (2018-2029) & (US$ Million)

    Figure 81. Mexico Human Cytomegalovirus Envelope Glycoprotein B Revenue (2018-2029) & (US$ Million)

    Figure 82. Turkey Human Cytomegalovirus Envelope Glycoprotein B Revenue (2018-2029) & (US$ Million)

    Figure 83. Israel Human Cytomegalovirus Envelope Glycoprotein B Revenue (2018-2029) & (US$ Million)

    Figure 84. GCC Countries Human Cytomegalovirus Envelope Glycoprotein B Revenue (2018-2029) & (US$ Million)

    Figure 85. Human Cytomegalovirus Envelope Glycoprotein B Value Chain

    Figure 86. Human Cytomegalovirus Envelope Glycoprotein B Production Process

    Figure 87. Channels of Distribution

    Figure 88. Distributors Profiles

    Figure 89. Bottom-up and Top-down Approaches for This Report

    Figure 90. Data Triangulation

    Figure 91. Key Executives Interviewed